US20010044649A1 - Stents for angioplasty - Google Patents

Stents for angioplasty Download PDF

Info

Publication number
US20010044649A1
US20010044649A1 US09/410,303 US41030399A US2001044649A1 US 20010044649 A1 US20010044649 A1 US 20010044649A1 US 41030399 A US41030399 A US 41030399A US 2001044649 A1 US2001044649 A1 US 2001044649A1
Authority
US
United States
Prior art keywords
segment
stent
annular
segments
bridge elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/410,303
Other versions
US6451049B2 (en
Inventor
Franco Vallana
Giovanni Rolando
Maria Curcio
Paolo Gaschino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CID SpA
Original Assignee
Sorin Biomedica Cardio SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/069,425 external-priority patent/US6325821B1/en
Application filed by Sorin Biomedica Cardio SpA filed Critical Sorin Biomedica Cardio SpA
Priority to US09/410,303 priority Critical patent/US6451049B2/en
Assigned to SORIN BIOMEDICA CARDIO S.P.A. reassignment SORIN BIOMEDICA CARDIO S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CURCIO, MARIA, Gashino, Paolo, ROLANDO, GIOVANNI, VALLANA, FRANCO
Priority to DK00120834T priority patent/DK1088528T3/en
Priority to ES00120834T priority patent/ES2274758T3/en
Priority to DE60031490T priority patent/DE60031490T2/en
Priority to EP00120834A priority patent/EP1088528B1/en
Priority to AT00120834T priority patent/ATE343355T1/en
Publication of US20010044649A1 publication Critical patent/US20010044649A1/en
Priority to US10/159,969 priority patent/US7273494B2/en
Publication of US6451049B2 publication Critical patent/US6451049B2/en
Application granted granted Critical
Priority to US11/860,805 priority patent/US20080288048A1/en
Assigned to SORIN BIOMEDICA CARDIO S.R.L. reassignment SORIN BIOMEDICA CARDIO S.R.L. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SORIN BIOMEDICA CARDIO S.P.A.
Assigned to INTERVASCULAR C.V. reassignment INTERVASCULAR C.V. EXCERPTED ASSET PURCHASE AGREEMENT Assignors: SORIN BIOMEDICA CARDIO S.R.L.
Assigned to INTERVASCULAR C.V. reassignment INTERVASCULAR C.V. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SORIN BIOMEDICA CARDIO S.R.L.
Priority to US12/793,341 priority patent/US20100241216A1/en
Assigned to CID S.P.A. reassignment CID S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INTERVASCULAR C.V.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91583Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0036Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness

Definitions

  • the present invention relates to stents for angioplasty.
  • the invention relates to a stent having a cellular design.
  • stent is intended to indicate devices useful for endoluminal insertion (for example, in a blood vessel), usually effected by means of catheterization, with subsequent deployment in place so as to achieve local support of the lumen.
  • the primary purpose of the stent is to eliminate and avoid the restenosis (i.e., narrowing or closure) of the treated area.
  • the stent while moving toward the treatment site, the stent should be capable of adapting to the path, which may include various curved sections;
  • distortion of the stent while it is being positioned should not be detrimental to the ability of the stent to provide an effective support when it is positioned and deployed;
  • an extensive support surface should be provided to the wall of the lumen which is being supported
  • the stents should be able to be simply and reliably produced using available technology and they should incorporate the requirements listed above.
  • a stent is subject to various forces, including compression, flexure, and torsion. These stresses often cause the stent to perform in an undesirable manner. Additionally, a significant disadvantage of current stent designs is their failure to distribute these stresses throughout the structure of the stent. Each of these stresses is maximized in a particular area of the stent. In current stent designs two or more of these areas of maximum stress overlap. This results in at least two problems. First, an overlap of the maximum stress areas may overly fatigue the stent and cause failure in an area of overlapped maximum stress. Second, the failure to distribute or discharge the maximum stress of these forces at different areas causes stress concentration on the vessel wall which may cause vessel wall injury. Thus what is needed in the art is a stent meeting the requirements listed above that will avoid stress concentration and elastic distortion as well as provide good elastic matching between the stent and the vessel into which it is placed.
  • This invention is a stent having a substantially tubular body defining a longitudinal axis comprising first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment; a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment.
  • the U-shaped portion of the plurality of bridge elements may be oriented in the same direction. Alternately, they may be oriented in one direction between one pair of adjacent annular segments, and in the opposite direction between another pair of adjacent annular segments.
  • the connector arm of the bridge element joins the annular segment at the zero point of the sinusoidal wave shape.
  • each connector arm joins each annular segment at zero points of the sinusoidal wave separated by 360°. Alternately, the connector arms may join zero points separated by 360° between one pair of adjacent segments, and zero points separated by 720° between another pair of adjacent segments.
  • this invention is a method of preventing restenosis by providing the stent described above and deploying it within a body lumen.
  • this invention is a method of making a stent by providing a tubular blank and forming the tubular blank into a stent having the geometry described above.
  • this invention is a stent having a substantially tubular body defining a longitudinal axis.
  • the stent comprises first and second adjacent annular segments, each segment having a substantially sinusoidal wave shape.
  • the stent further includes first and second bridge elements, the first bridge element having a first end connected to the first annular segment at a zero point of the sinusoidal wave shape and having a second end connected to the second annular segment at a zero point of the sinusoidal wave shape.
  • the second bridge element has a first end connected to the first annular segment at a zero point of the sinusoidal wave shape spaced 360° from the connection of the first bridge element to the first annular segment and a second end connected to the second annular segment at a zero point of the sinusoidal wave shape 360° from the connection of the first bridge element to the second segment, the first and second bridge elements and a portion of the first and second annular segments between the connection points of the bridge elements together defining a cell.
  • the invention is a stent having a substantially tubular body defining a longitudinal axis and having a plurality of annular segments, each segment having a substantially sinusoidal wave shape.
  • the stent includes a plurality of bridge elements, each bridge element having a first end connected to one annular segment at a zero point of the sinusoidal wave shape and a second end connected to an annular segment adjacent to the one annular segment at a zero point of the sinusoidal wave shape of the adjacent annular segment, the annular segments and bridge elements being configured such that when compression, flexure and torsion forces are applied to the stent they generate first maximum stress regions, second maximum stress regions, and third maximum stress regions, where the first, second and third maximum stress regions do not overlap.
  • FIG. 1 is a plan view of the tubular stent of the present invention cut longitudinally and opened to lie within a single plane, the stent being in a radially contracted configuration.
  • FIG. 2 illustrates the stent of FIG. 1 in its radially expanded configuration.
  • FIG. 3( a ) illustrates an expanded view of a single cell within the wall of the stent of FIG. 2 and FIGS. 3 ( b ), 3 ( c ), 3 ( d ), 3 ( c ) and 3 ( f ) show the cross-sectional areas of portions of the stent.
  • FIGS. 4 ( a ) to 4 ( f ) illustrate the effects of compression, flexure, and torsion, respectively, on a cell of the stent of this invention.
  • FIGS. 5 ( a ) to 5 ( f ) illustrate various shapes of the wall of a continuous tubular blank used to make the stent of this invention.
  • FIGS. 6 ( a ) and 6 ( b ) illustrate the variation in cross section of a section of the stent of this invention.
  • FIG. 7 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
  • FIG. 8 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
  • FIG. 9 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
  • FIG. 10 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
  • a stent is inserted into a lumen, such as a blood vessel, at a site where stenosis, i.e., narrowing or stricture, is to be corrected.
  • the stent is a tubular envelope, tubular body, or cylinder having apertured walls, such as, for example, a mesh-like structure.
  • the stent typically has dimensions between several millimeters and several tens of millimeters in length, and a wall thickness of the order of, for example, several hundredths of millimeters.
  • the stent is normally positioned in situ by catheterization through the vasculature followed by radial expansion from an introduction diameter of, for example, about 1.0 to 1.5 mm, to an expanded diameter of, for example, about 3 to 4 mm.
  • the stent exerts a supporting force on the lumen, thereby avoiding or at least slowing restenosis of the vessel.
  • the external diameter of the stent in the radially-contracted condition is chosen to enable the introduction of the stent into a lumen, while the expanded diameter corresponds to the diameter required to be maintained in the lumen once the stenosis has been eliminated. It should also be remembered that, although the principle application of the stent described is in relation to the treatment of blood vessels, it may also be useful as a support element for any lumen present in the human or animal body.
  • the stent of this invention is a tubular body, i.e., a cylinder, with an open, or apertured, mesh-like structure.
  • the stent is capable of being dilated from a radially-contracted position to a radially-expanded position.
  • the tubular body is comprised of a wall having an inner surface and an outer surface defining a radial stent thickness therebetween.
  • the material making up the mesh-like structure of the stent varies in its cross-sectional shape and/or cross-sectional area.
  • this cross-sectional variation (and thus a variation in thickness and/or width in the stent wall) produces a particularly desirable stent because the strength, flexibility, and support of the stent may be varied in localized areas.
  • the width as measured along the circumference of the tubular body and/or the radial thickness are made smaller to enhance flexibility.
  • the width and/or thickness are made larger.
  • the width is increased to provide added vascular support.
  • the stent is shown in planar views so that the geometry of the stent may be seen easily.
  • the body of the stent extends longitudinally in the direction identified as the Z axis. It also lies in the Z plane, i.e., a plane coincident with the Z axis.
  • the stent may be flexed, bent or folded; thus good flexibility is one of the required characteristics of the stent.
  • Another important characteristic of both the design and the material of the stent includes strength, i.e., the ability to withstand stresses due to compression, flexure, and torsion, as discussed further below.
  • FIG. 1 illustrates a plan view of the stent of this invention.
  • the body of stent 1 is comprised of a plurality of successive segments 2 of generally annular form.
  • FIG. 1 shows a stent comprising eight annular segments 2 .
  • the length of segments 2 measured in the longitudinal direction may range up to several millimeters (mm) but preferably is approximately 2 mm. That is, segments 2 are fairly “short” in comparison to the total length of the stent.
  • bridge elements 8 which are actually integral components of the stent wall that connect adjacent segments 2 and enable stent 1 to flex or bend.
  • Radiopaque marker 13 optionally is provided. Marker 13 is integral with segments 2 and typically is located on the proximal and/or distal ends of the stent. “Proximal and distal ends” refers to the portion of the stent nearest and farthest, respectively, from the point of entry of the stent into the vasculature. Suitable radiopaque markers include metals such as platinum, tantalum, gold, and alloys of these metals. Such markers permit exact placement of a stent within the vasculature of a patient. During manufacture the radiopaque marker may be crimped into a hole in the stent wall.
  • the longitudinal flexibility of stent 1 necessary to assist in its delivery and location at the implantation site, is essentially due to bridge elements 8 , while its structural strength, that is, its support of the lumen, is due primarily to the structure of segments 2 .
  • the desired characteristics of the stent can be obtained by adapting the arrangement and relationship of the bridge elements and the segments.
  • FIG. 1 shows a plan view of a stent which has been cut open and laid flat; that is, the stent is no longer in a tubular shape.
  • FIG. 1 illustrates that each segment 2 has a serpentine or sinusoidal wave shape.
  • Each segment comprises peaks 4 and valleys 6 .
  • Each annular segment is a mirror image of an adjacent annular segment about a plane perpendicular to the longitudinal axis of the stent. Thus, the peaks of one segment are aligned longitudinally with valleys of an adjacent segment.
  • the term “sinusoidal wave shape” means that the annular segments have an undulating repeating pattern similar to that of a sine wave. It is not intended to mean that the shape is limited to that of a sine wave.
  • Bridge elements 8 separate adjacent segments and maintain a distance between them in both the expanded and contracted conditions.
  • Each bridge element 8 comprises a concave portion, or U-shape 10 , having apex 12 .
  • the U-shape is adjoined to two connector arms 14 which extend from the U-shape and adjoin adjacent sinusoidal-shaped segments 2 at a zero point of the sinusoidal wave shape of each segment.
  • the point of connection is between a peak and a valley of each segment such that the apex of the U-shape extends in the direction of the converging peak and valley that is nearest the attachment of the connector arm. These arms extend away from the U-shape and curve back to join the segments in the direction of the apex of the U-shape.
  • these arms form an angle ⁇ of about 90 degrees with the U-shape.
  • Bridge elements 8 are relatively flexible and change shape only slightly from the contracted to the expanded condition, as can be seen in FIGS. 1 and 2.
  • Arms 14 adjoin adjacent sinusoidal wave shaped segments between a peak and a valley and preferably at zero-point 11 of the sinusoidal shape. (On a sine curve plotted on an X and Y axis, the “zero-point” is that point that intersects the X axis.)
  • FIGS. 1 and 2 illustrate an embodiment of the stent of this invention wherein the connector arms of each bridge element adjoin alternate zero points of each adjacent segment. That is, in terms of the sinusoidal wave shape of each segment, bridge elements are connected at zero points separated by 360°. This results in even spacing of bridge elements between adjacent segments.
  • the bridge elements are oriented in the same direction; that is, the U-shaped portion of each bridge element faces the same direction. It has been found that connection of the bridge elements at the zero points not only produces a very elastic joint but also results in the longitudinal length of the stent being the same in the contracted condition and the expanded condition and in all degrees of expansion therebetween.
  • FIG. 1 A radially-contracted condition of the stent is illustrated in FIG. 1. This condition is slightly expanded from the stents fully contracted delivery condition so that the details of the stents structure may be more clearly shown.
  • FIG. 2 shows that a segment 2 is elongated compared to the same segment in FIG. 1. That is, the segments retain the sinusoidal shape, but the amplitude and the frequency of the sine wave is less in the expanded condition than in the contracted condition.
  • FIGS. 1 and 2 also show that the connector arms 14 remain substantially parallel to the longitudinal axis of the stent in both the radially contracted position (FIG. 1) and radially expanded position (FIG. 2).
  • FIG. 3( a ) is a view of one cell of the stent of FIG. 2.
  • FIGS. 1 and 2 illustrate that the stent is made up of individual, interconnected cells, each cell having the same size and shape.
  • FIGS. 3 ( b ) to 3 ( f ) illustrate that the cross sectional shape and area of the material making up the stent varies over the cell.
  • the perimeter of a cell is formed from portions of adjacent sinusoidal segments ( 2 a and 2 b ) and two bridge elements ( 8 a and 8 b ).
  • Sinusoidal segment portions 2 a and 2 b are 360° portions of the sinusoidal wave shape of the annular segments.
  • Arms 14 a and 14 a ′ extend from U-shape portion 10 a of bridge element 8 a .
  • Apex 12 a of bridge 8 a is oriented in the same direction as apex 12 b of bridge 8 b .
  • Bridges 8 a and 8 b adjoin adjacent segments 2 a and 2 b at zero points 11 of the sinusoidal shape; that is, between the peaks and valleys of the segments.
  • Bridge element 8 b having U-shape 10 b , apex 12 b , and arms 14 b and 14 b ′, forms the remainder of the cell.
  • FIGS. 3 ( b ), 3 ( c ), 3 ( d ), 3 ( e ) and 3 ( f ) show the shape and size of the cross-section of different portions of the cell taken along lines b-b, c-c, d-d, e-e and f-f respectively. It is preferred that the cross-sectional area of the material making up the stent vary. The cross-sectional shape may vary as well. An alternate way of describing this is that the width of the material making up the stent of FIGS.
  • 1 and 2 may be different than the thickness of that portion (i.e., the dimension in a plane X, perpendicular to plane Z). It has been found that varying the cross-sectional area of different portions of the material of the stent produces optimum strength, flexibility, and support, enabling the stent to accommodate the differing stresses it encounters during use.
  • FIGS. 4 ( a ) to 4 ( f ) illustrate the effects of compression, flexure, and torsion, respectively, on one cell of the stent of this invention.
  • the arrows indicate the direction of the forces applied to the stent.
  • the areas of the stent cell having the greatest stress concentration are indicated by solid lines.
  • FIG. 4( a ) the stent is subjected to a compression force.
  • FIG. 4( b ) shows that the areas of greatest stress occurs at the peaks and valleys of the sinusoidal shaped segments.
  • FIG. 4( c ) shows s stent undergoing flexure.
  • FIG. 4( d ) indicates that the areas of greatest stress occur at the apex of the U-shape of the bridge.
  • FIG. 4( e ) shows a stent under torsion.
  • FIG. 4( f ) indicates that the maximum stress occurs at the areas where the bridge joins the sinusoidal shaped segments, i.
  • the stents of this invention it is possible to alter the thickness and width of various portions of the stent during the manufacturing process.
  • One way to do this is to form the desired wall geometry in a continuous tubular blank and then cut or machine the stent from this blank.
  • techniques such as laser incision, photo-incision, and electroerosion may be used to form a desired geometry. In this way, the stent bridges and sinusoidal segments are formed.
  • FIG. 5 a shows a continuous tubular blank from which stents can be formed.
  • the tubular blank has outer surface 51 forming the outer diameter and inner surface 53 forming the inner diameter; surfaces 51 and 53 are separated by wall thickness 55 .
  • the characteristics of the stent including wall thickness and shape can be varied in accordance with the shape and surface configuration of inner and outer surfaces 53 and 51 of the tubular blank. Accordingly, the wall of the stent may be formed so that it has a variety of cross sectional shapes.
  • FIGS. 5 ( b ) to 5 ( f ) show a section or slice of differently shaped tubular blanks between lines a-a′ and illustrate various wall shapes.
  • the inner and outer surfaces of the tubular blank may be substantially parallel as in FIG. 5 b .
  • FIGS. 5 ( e ) and 5 ( f ) illustrate tube walls having variable inside and outside diameters. Such tubular blanks are then machined to form the desired stent as described above. The result is that the desired thicknesses and widths can be provided to different portions of the stent.
  • FIGS. 6 ( a ) and 6 ( b ) show a further embodiment of the invention and illustrate how the shape of the wall of a continuous tubular blank corresponds to the stent of this invention.
  • FIG. 6( a ) shows a longitudinal cross-section of a portion of a tubular blank having a constant inner diameter but varying outer diameter. This blank is then used to form the sinusoidal segments and bridges of the stent.
  • FIG. 6( b ) shows that the regions of the bridges adjoining the sinusoidal shaped segments (i.e., at the zero point) may be made with a smaller thickness than the remaining portions of the stent.
  • This stent comprises bridge elements 78 adjoining sinusoidal shaped segments 72 at zero points 71 of the sinusoidal shape.
  • the bridge elements are evenly spaced.
  • the bridge elements are spaced apart 720° along the sinusoidal shape of the segments.
  • the apices of each bridge element face the same direction.
  • the stent of FIG. 4 illustrates cells all having the same shape and size. In contrast to FIGS. 1 and 2, this stent has fewer connecting bridges and fewer cells.
  • the stent of FIG. 8 is a hybrid of FIGS. 1 and 6.
  • Bridge elements 88 adjoin adjacent segments 82 at zero points 81 of the sinusoidal shape. All bridge elements are oriented similarly (i.e., face the same direction). The bridge elements adjoining adjacent segments are evenly spaced. However, the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size and may produce regions of variable flexibility as well as strength.
  • An advantage to having a greater number of bridge elements (and hence cells) at either end of the stent is that they provide additional stability and strength to the ends of the stent while having fewer cells in the middle portion of the stent provides additional flexibility.
  • FIG. 9 Another variation of the stent is illustrated in FIG. 9.
  • the bridge elements are evenly spaced throughout the stent, forming cells all of equal size and shape.
  • apices for example, 90 a and 90 b
  • bridge elements 98 face opposite directions in adjacent pairs of segments 92 .
  • FIG. 10 illustrates yet another variation of the stent, wherein U-shaped portions 100 a and 100 b of bridge elements 108 a and 108 b , respectively, are facing in opposite directions in adjacent pairs of segments 102 and wherein the cells formed at each end of the stent are of different size than those of the remaining cells.
  • the bridge elements adjoining any pair of adjacent segments are evenly spaced, but the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size, and, in similar fashion to FIG. 8, produces regions of greater strength at either end of the stent.
  • the bridge elements between adjacent sinusoidal segments with the apices pointing in the direction of a converging peak and valley of the adjacent segments.
  • This configuration provides a number of advantages.
  • One advantage is that, in the expanded configuration, the stent cell structure is sufficiently open to permit access to the lumen. For example, it is possible to manipulate catheters through the stent wall into vessel bifurcations in order to treat those vessels.
  • Another advantage is that the stent geometry provides a smooth profile for delivery when in the contracted position.
  • the U-shape of the connecting bridges lies between a converging valley and peak of adjacent sinusoidal segments and acts as a bridge therebetween.
  • peaks or valleys of some prior art stents protrude especially when the stent is bent during delivery. This protruding peak or valley can snag on a vessel wall or plaque, making delivery and positioning of the stent difficult.
  • a further advantage is provided by the configuration of the bridge elements.
  • the connector arms and U-shaped portion of the bridge elements act in cooperation with the segments to provide an effective support surface for the vessel wall while at the same time minimizing the amount of stent material which must be used.
  • the most widely used method is to use a balloon catheter, disposing the stent about the balloon of the catheter in the contracted condition and then expanding the balloon once the stent has been delivered to the deployment site.
  • Different solutions are also possible, such as using superelastic materials that expand when the stent reaches the implantation site. Typically these materials are held in a contracted condition by means of a containment element that is released when the stent has reached the desired location and position.
  • Materials having a “shape memory” that expand from a first configuration to a second expanded configuration when heated to a transition temperature (i.e., body temperature) also may be used in order to achieve the radial expansion in the implant position.
  • the stent is made from a metal capable of satisfying two fundamental requirements: the ability to deform during the expansion phase and the ability to resist forces which could lead to contraction of the stent. That is, the stent retains the expanded shape.
  • the stents of this invention may comprise 316 stainless steel or a shape memory material known under the commercial designation “Nitinol”. “Nitinol” is a nickel-titanium alloy that has been shown to be successful due to its superelasticity as well as its shape memory. Stents also may comprise biodegradable and/or biocompatible polymers, as known to one of skill in the art.
  • the stent of this invention comprises a tubular body with an apertured wall.
  • Methods of making the stent include:
  • forming the stent from a continuous tubular blank intended to be segmented into individual stents, with the apertured parts being formed using techniques such as laser incision, photo-incision, electroerosion, and the like;
  • the first arrangement described is the one currently preferred for producing stents of this invention.
  • the use of laser beams to cut a continuous tubular blank has been shown to be the most flexible way to modify rapidly the characteristics of the stent during production.
  • Such methods may be used to produce a stent having either constant or variable wall thickness, and, in either case, with wall material having different cross-sections. These methods include making the stent from a continuous tubular blank and machining, grinding, chemically etching, or electron discharge machining the tube to produce the desired pattern and also obtain sections of desired cross-section. Alternatively, a tubular blank having constant or variable thickness down its length could be laser cut to form the desired arrangement of segments and bridges. A stent could be formed and then the inside surface could be turned or micro-etched.
  • the production method is not critical to the stents of this invention, as they may be formed by any desired method. This applies to the choice of the individual techniques and the order in which the various operations (the production of the apertured parts, segmentation, possible folding of the strip-like element, etc.) are performed.

Abstract

This invention is a stent having a substantially tubular body defining a longitudinal axis comprising first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment. The stent has a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment. The bridge elements may be connected to the segments at points spaced 360° apart along the sinusoidal shape of the segments. The segments and bridge elements are configured such that when compression, flexure, and torsion forces are applied to the stent they generate first maximum stress regions, second maximum stress regions and third maximum stress regions which do not overlap.

Description

    FIELD OF THE INVENTION
  • The present invention relates to stents for angioplasty. In particular, the invention relates to a stent having a cellular design. [0001]
  • BACKGROUND OF THE INVENTION
  • The term “stent” is intended to indicate devices useful for endoluminal insertion (for example, in a blood vessel), usually effected by means of catheterization, with subsequent deployment in place so as to achieve local support of the lumen. The primary purpose of the stent is to eliminate and avoid the restenosis (i.e., narrowing or closure) of the treated area. [0002]
  • For a general review of vascular stents, reference is made to “Textbook of Interventional Cardiology” edited by Eric J Topol, W. B. Saunders Company, 1994 and, in particular, to section IV of volume II, entitled “Coronary Stenting”. [0003]
  • Many patents also provide a general review of stents, for example, U.S. Pat. Nos. 4,503,569; 4,768,507; 4,776,337; 4,800,882; 4,830,003; 4,856,516; 4,886,062; 4,907,336; and EP 0 201 466A. [0004]
  • Notwithstanding the extensive research and experimentation in the stent field, as documented in the patent literature, only a relatively small number of operative solutions have, until now, found practical application. This is due to various factors, which include the following problems or requirements: [0005]
  • while moving toward the treatment site, the stent should be capable of adapting to the path, which may include various curved sections; [0006]
  • distortion of the stent while it is being positioned should not be detrimental to the ability of the stent to provide an effective support when it is positioned and deployed; [0007]
  • the longitudinal shortening effect which occurs in many stents upon deployment should be limited, if not avoided; [0008]
  • maximum homogeneity and uniformity in the expansion of the stent should be achieved at the desired location; [0009]
  • an extensive support surface should be provided to the wall of the lumen which is being supported; [0010]
  • the origination of complex shapes and/or possible stagnation sites, especially in blood vessels, should be avoided, in order to avoid undesirable phenomena such as coagulation or thrombosis; and [0011]
  • the stents should be able to be simply and reliably produced using available technology and they should incorporate the requirements listed above. [0012]
  • A stent is subject to various forces, including compression, flexure, and torsion. These stresses often cause the stent to perform in an undesirable manner. Additionally, a significant disadvantage of current stent designs is their failure to distribute these stresses throughout the structure of the stent. Each of these stresses is maximized in a particular area of the stent. In current stent designs two or more of these areas of maximum stress overlap. This results in at least two problems. First, an overlap of the maximum stress areas may overly fatigue the stent and cause failure in an area of overlapped maximum stress. Second, the failure to distribute or discharge the maximum stress of these forces at different areas causes stress concentration on the vessel wall which may cause vessel wall injury. Thus what is needed in the art is a stent meeting the requirements listed above that will avoid stress concentration and elastic distortion as well as provide good elastic matching between the stent and the vessel into which it is placed. [0013]
  • SUMMARY OF THE INVENTION
  • This invention is a stent having a substantially tubular body defining a longitudinal axis comprising first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment; a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment. [0014]
  • The U-shaped portion of the plurality of bridge elements may be oriented in the same direction. Alternately, they may be oriented in one direction between one pair of adjacent annular segments, and in the opposite direction between another pair of adjacent annular segments. Preferably, the connector arm of the bridge element joins the annular segment at the zero point of the sinusoidal wave shape. In one embodiment, each connector arm joins each annular segment at zero points of the sinusoidal wave separated by 360°. Alternately, the connector arms may join zero points separated by 360° between one pair of adjacent segments, and zero points separated by 720° between another pair of adjacent segments. [0015]
  • In a second aspect, this invention is a method of preventing restenosis by providing the stent described above and deploying it within a body lumen. [0016]
  • In a third aspect, this invention is a method of making a stent by providing a tubular blank and forming the tubular blank into a stent having the geometry described above. [0017]
  • In a further aspect this invention is a stent having a substantially tubular body defining a longitudinal axis. The stent comprises first and second adjacent annular segments, each segment having a substantially sinusoidal wave shape. The stent further includes first and second bridge elements, the first bridge element having a first end connected to the first annular segment at a zero point of the sinusoidal wave shape and having a second end connected to the second annular segment at a zero point of the sinusoidal wave shape. The second bridge element has a first end connected to the first annular segment at a zero point of the sinusoidal wave shape spaced 360° from the connection of the first bridge element to the first annular segment and a second end connected to the second annular segment at a zero point of the sinusoidal wave shape 360° from the connection of the first bridge element to the second segment, the first and second bridge elements and a portion of the first and second annular segments between the connection points of the bridge elements together defining a cell. [0018]
  • In a further aspect, the invention is a stent having a substantially tubular body defining a longitudinal axis and having a plurality of annular segments, each segment having a substantially sinusoidal wave shape. The stent includes a plurality of bridge elements, each bridge element having a first end connected to one annular segment at a zero point of the sinusoidal wave shape and a second end connected to an annular segment adjacent to the one annular segment at a zero point of the sinusoidal wave shape of the adjacent annular segment, the annular segments and bridge elements being configured such that when compression, flexure and torsion forces are applied to the stent they generate first maximum stress regions, second maximum stress regions, and third maximum stress regions, where the first, second and third maximum stress regions do not overlap. [0019]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will now be described with reference to the accompanying drawings. [0020]
  • FIG. 1 is a plan view of the tubular stent of the present invention cut longitudinally and opened to lie within a single plane, the stent being in a radially contracted configuration. [0021]
  • FIG. 2 illustrates the stent of FIG. 1 in its radially expanded configuration. [0022]
  • FIG. 3([0023] a) illustrates an expanded view of a single cell within the wall of the stent of FIG. 2 and FIGS. 3(b), 3(c), 3(d), 3(c) and 3(f) show the cross-sectional areas of portions of the stent.
  • FIGS. [0024] 4(a) to 4(f) illustrate the effects of compression, flexure, and torsion, respectively, on a cell of the stent of this invention.
  • FIGS. [0025] 5(a) to 5(f) illustrate various shapes of the wall of a continuous tubular blank used to make the stent of this invention.
  • FIGS. [0026] 6(a) and 6(b) illustrate the variation in cross section of a section of the stent of this invention.
  • FIG. 7 is a view similar to FIG. 1 of another embodiment of the stent of this invention. [0027]
  • FIG. 8 is a view similar to FIG. 1 of another embodiment of the stent of this invention. [0028]
  • FIG. 9 is a view similar to FIG. 1 of another embodiment of the stent of this invention. [0029]
  • FIG. 10 is a view similar to FIG. 1 of another embodiment of the stent of this invention. [0030]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • A stent is inserted into a lumen, such as a blood vessel, at a site where stenosis, i.e., narrowing or stricture, is to be corrected. The stent is a tubular envelope, tubular body, or cylinder having apertured walls, such as, for example, a mesh-like structure. The stent typically has dimensions between several millimeters and several tens of millimeters in length, and a wall thickness of the order of, for example, several hundredths of millimeters. The stent is normally positioned in situ by catheterization through the vasculature followed by radial expansion from an introduction diameter of, for example, about 1.0 to 1.5 mm, to an expanded diameter of, for example, about 3 to 4 mm. In this expanded condition, the stent exerts a supporting force on the lumen, thereby avoiding or at least slowing restenosis of the vessel. In general, the external diameter of the stent in the radially-contracted condition is chosen to enable the introduction of the stent into a lumen, while the expanded diameter corresponds to the diameter required to be maintained in the lumen once the stenosis has been eliminated. It should also be remembered that, although the principle application of the stent described is in relation to the treatment of blood vessels, it may also be useful as a support element for any lumen present in the human or animal body. [0031]
  • The stent of this invention is a tubular body, i.e., a cylinder, with an open, or apertured, mesh-like structure. The stent is capable of being dilated from a radially-contracted position to a radially-expanded position. The tubular body is comprised of a wall having an inner surface and an outer surface defining a radial stent thickness therebetween. In one embodiment, the material making up the mesh-like structure of the stent varies in its cross-sectional shape and/or cross-sectional area. It has been discovered that this cross-sectional variation (and thus a variation in thickness and/or width in the stent wall) produces a particularly desirable stent because the strength, flexibility, and support of the stent may be varied in localized areas. In areas requiring flexibility, the width as measured along the circumference of the tubular body and/or the radial thickness are made smaller to enhance flexibility. In areas requiring strength, the width and/or thickness are made larger. In areas not requiring flexibility, the width is increased to provide added vascular support. [0032]
  • In the embodiments illustrated in the Figures, the stent is shown in planar views so that the geometry of the stent may be seen easily. The body of the stent extends longitudinally in the direction identified as the Z axis. It also lies in the Z plane, i.e., a plane coincident with the Z axis. During delivery and use of the stent, the stent may be flexed, bent or folded; thus good flexibility is one of the required characteristics of the stent. Another important characteristic of both the design and the material of the stent includes strength, i.e., the ability to withstand stresses due to compression, flexure, and torsion, as discussed further below. [0033]
  • FIG. 1 illustrates a plan view of the stent of this invention. The body of stent [0034] 1 is comprised of a plurality of successive segments 2 of generally annular form. FIG. 1 shows a stent comprising eight annular segments 2. Typically, the length of segments 2 measured in the longitudinal direction (i.e., along the Z axis) may range up to several millimeters (mm) but preferably is approximately 2 mm. That is, segments 2 are fairly “short” in comparison to the total length of the stent.
  • The various segments of stent [0035] 1 are joined together by bridge elements 8 (which are actually integral components of the stent wall) that connect adjacent segments 2 and enable stent 1 to flex or bend.
  • [0036] Radiopaque marker 13 optionally is provided. Marker 13 is integral with segments 2 and typically is located on the proximal and/or distal ends of the stent. “Proximal and distal ends” refers to the portion of the stent nearest and farthest, respectively, from the point of entry of the stent into the vasculature. Suitable radiopaque markers include metals such as platinum, tantalum, gold, and alloys of these metals. Such markers permit exact placement of a stent within the vasculature of a patient. During manufacture the radiopaque marker may be crimped into a hole in the stent wall.
  • The longitudinal flexibility of stent [0037] 1, necessary to assist in its delivery and location at the implantation site, is essentially due to bridge elements 8, while its structural strength, that is, its support of the lumen, is due primarily to the structure of segments 2. The desired characteristics of the stent can be obtained by adapting the arrangement and relationship of the bridge elements and the segments.
  • FIG. 1 shows a plan view of a stent which has been cut open and laid flat; that is, the stent is no longer in a tubular shape. FIG. 1 illustrates that each [0038] segment 2 has a serpentine or sinusoidal wave shape. Each segment comprises peaks 4 and valleys 6. Each annular segment is a mirror image of an adjacent annular segment about a plane perpendicular to the longitudinal axis of the stent. Thus, the peaks of one segment are aligned longitudinally with valleys of an adjacent segment. For purposes of this description the term “sinusoidal wave shape” means that the annular segments have an undulating repeating pattern similar to that of a sine wave. It is not intended to mean that the shape is limited to that of a sine wave.
  • [0039] Bridge elements 8 separate adjacent segments and maintain a distance between them in both the expanded and contracted conditions. Each bridge element 8 comprises a concave portion, or U-shape 10, having apex 12. The U-shape is adjoined to two connector arms 14 which extend from the U-shape and adjoin adjacent sinusoidal-shaped segments 2 at a zero point of the sinusoidal wave shape of each segment. The point of connection is between a peak and a valley of each segment such that the apex of the U-shape extends in the direction of the converging peak and valley that is nearest the attachment of the connector arm. These arms extend away from the U-shape and curve back to join the segments in the direction of the apex of the U-shape. Preferably these arms form an angle α of about 90 degrees with the U-shape. Bridge elements 8 are relatively flexible and change shape only slightly from the contracted to the expanded condition, as can be seen in FIGS. 1 and 2. Arms 14 adjoin adjacent sinusoidal wave shaped segments between a peak and a valley and preferably at zero-point 11 of the sinusoidal shape. (On a sine curve plotted on an X and Y axis, the “zero-point” is that point that intersects the X axis.)
  • FIGS. 1 and 2 illustrate an embodiment of the stent of this invention wherein the connector arms of each bridge element adjoin alternate zero points of each adjacent segment. That is, in terms of the sinusoidal wave shape of each segment, bridge elements are connected at zero points separated by 360°. This results in even spacing of bridge elements between adjacent segments. In addition, the bridge elements are oriented in the same direction; that is, the U-shaped portion of each bridge element faces the same direction. It has been found that connection of the bridge elements at the zero points not only produces a very elastic joint but also results in the longitudinal length of the stent being the same in the contracted condition and the expanded condition and in all degrees of expansion therebetween. [0040]
  • A radially-contracted condition of the stent is illustrated in FIG. 1. This condition is slightly expanded from the stents fully contracted delivery condition so that the details of the stents structure may be more clearly shown. The radially-expanded condition of the stent shown in FIG. 2. FIG. 2 shows that a [0041] segment 2 is elongated compared to the same segment in FIG. 1. That is, the segments retain the sinusoidal shape, but the amplitude and the frequency of the sine wave is less in the expanded condition than in the contracted condition. FIGS. 1 and 2 also show that the connector arms 14 remain substantially parallel to the longitudinal axis of the stent in both the radially contracted position (FIG. 1) and radially expanded position (FIG. 2).
  • An alternative way of describing the structure of the stents of this invention is in terms of its substantially tubular surface which includes multiple cells. FIG. 3([0042] a), is a view of one cell of the stent of FIG. 2. FIGS. 1 and 2 illustrate that the stent is made up of individual, interconnected cells, each cell having the same size and shape. FIGS. 3(b) to 3(f) illustrate that the cross sectional shape and area of the material making up the stent varies over the cell. The perimeter of a cell is formed from portions of adjacent sinusoidal segments (2 a and 2 b) and two bridge elements (8 a and 8 b). Sinusoidal segment portions 2 a and 2 b are 360° portions of the sinusoidal wave shape of the annular segments. Arms 14 a and 14 a′ extend from U-shape portion 10 a of bridge element 8 a. Apex 12 a of bridge 8 a is oriented in the same direction as apex 12 b of bridge 8 b. Bridges 8 a and 8 b adjoin adjacent segments 2 a and 2 b at zero points 11 of the sinusoidal shape; that is, between the peaks and valleys of the segments. Bridge element 8 b, having U-shape 10 b, apex 12 b, and arms 14 b and 14 b′, forms the remainder of the cell.
  • FIGS. [0043] 3(b), 3(c), 3(d), 3(e) and 3(f) show the shape and size of the cross-section of different portions of the cell taken along lines b-b, c-c, d-d, e-e and f-f respectively. It is preferred that the cross-sectional area of the material making up the stent vary. The cross-sectional shape may vary as well. An alternate way of describing this is that the width of the material making up the stent of FIGS. 1 and 2 (i.e., the width of any portion of a bridge or a sinusoidal segment in plane Z) may be different than the thickness of that portion (i.e., the dimension in a plane X, perpendicular to plane Z). It has been found that varying the cross-sectional area of different portions of the material of the stent produces optimum strength, flexibility, and support, enabling the stent to accommodate the differing stresses it encounters during use.
  • Through the use of stress analysis of the stent, it has been determined that during use, different areas of the cells are stressed, depending upon the forces acting on the stent. For example, when the stent is under compression, stress is maximized in the peaks and valleys of the sinusoidal segments. When the stent is flexed, the stress is maximized around the apex of the U-shape of the bridge elements. Under torsion, the stress is maximized at the ends of the connector arms of the bridge elements, i.e., where a bridge element connects to a sinusoidal segment. [0044]
  • FIGS. [0045]   4(a) to 4(f) illustrate the effects of compression, flexure, and torsion, respectively, on one cell of the stent of this invention. The arrows indicate the direction of the forces applied to the stent. The areas of the stent cell having the greatest stress concentration are indicated by solid lines. In FIG. 4(a), the stent is subjected to a compression force. FIG. 4(b) shows that the areas of greatest stress occurs at the peaks and valleys of the sinusoidal shaped segments. FIG. 4(c) shows s stent undergoing flexure. FIG. 4(d) indicates that the areas of greatest stress occur at the apex of the U-shape of the bridge. FIG. 4(e) shows a stent under torsion. FIG. 4(f) indicates that the maximum stress occurs at the areas where the bridge joins the sinusoidal shaped segments, i.e., at the zero point.
  • It is an advantage of the cellular design of the stent of this invention that the areas of maximum stress induced by compression, flexure and torsion forces do not overlap. This reduces the risk that a particular area of the stent cell structure will be overly fatigued and fail. It also reduces the risk of causing damage to the vessel wall which can result if there is a significant stress concentration at any portion of the cellular structure. In the stent of this invention maximum stresses from compression, flexure and torsion are distributed and discharged over three separate areas of the cellular structure thus reducing the risk of stent failure and damage to vessel walls. [0046]
  • In the stents of this invention, it is possible to alter the thickness and width of various portions of the stent during the manufacturing process. One way to do this is to form the desired wall geometry in a continuous tubular blank and then cut or machine the stent from this blank. For example, techniques such as laser incision, photo-incision, and electroerosion may be used to form a desired geometry. In this way, the stent bridges and sinusoidal segments are formed. [0047]
  • FIG. 5[0048] a shows a continuous tubular blank from which stents can be formed. The tubular blank has outer surface 51 forming the outer diameter and inner surface 53 forming the inner diameter; surfaces 51 and 53 are separated by wall thickness 55. The characteristics of the stent including wall thickness and shape can be varied in accordance with the shape and surface configuration of inner and outer surfaces 53 and 51 of the tubular blank. Accordingly, the wall of the stent may be formed so that it has a variety of cross sectional shapes. FIGS. 5(b) to 5(f) show a section or slice of differently shaped tubular blanks between lines a-a′ and illustrate various wall shapes. The inner and outer surfaces of the tubular blank may be substantially parallel as in FIG. 5b. This is consistent with the embodiment shown in FIGS. 3(a) to 3(f). Alternatively, the surface configuration of the outer and/or inner surfaces may be varied as in FIGS. 5(c) to 5(f). For example, the inner diameter of the tube may be constant and the outer diameter may vary, as in FIG. 5(c), or the converse, as in FIG. 5(d), may be used. FIGS. 5(e) and 5(f) illustrate tube walls having variable inside and outside diameters. Such tubular blanks are then machined to form the desired stent as described above. The result is that the desired thicknesses and widths can be provided to different portions of the stent.
  • FIGS. [0049] 6(a) and 6(b) show a further embodiment of the invention and illustrate how the shape of the wall of a continuous tubular blank corresponds to the stent of this invention. FIG. 6(a) shows a longitudinal cross-section of a portion of a tubular blank having a constant inner diameter but varying outer diameter. This blank is then used to form the sinusoidal segments and bridges of the stent. FIG. 6(b) shows that the regions of the bridges adjoining the sinusoidal shaped segments (i.e., at the zero point) may be made with a smaller thickness than the remaining portions of the stent.
  • Turning now to FIG. 7, various alternative embodiments of the stent of this invention are illustrated. This stent comprises [0050] bridge elements 78 adjoining sinusoidal shaped segments 72 at zero points 71 of the sinusoidal shape. The bridge elements are evenly spaced. In this case the bridge elements are spaced apart 720° along the sinusoidal shape of the segments. The apices of each bridge element face the same direction. As described above, when viewed as a cellular structure, the stent of FIG. 4 illustrates cells all having the same shape and size. In contrast to FIGS. 1 and 2, this stent has fewer connecting bridges and fewer cells.
  • The stent of FIG. 8 is a hybrid of FIGS. 1 and 6. [0051] Bridge elements 88 adjoin adjacent segments 82 at zero points 81 of the sinusoidal shape. All bridge elements are oriented similarly (i.e., face the same direction). The bridge elements adjoining adjacent segments are evenly spaced. However, the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size and may produce regions of variable flexibility as well as strength. An advantage to having a greater number of bridge elements (and hence cells) at either end of the stent is that they provide additional stability and strength to the ends of the stent while having fewer cells in the middle portion of the stent provides additional flexibility.
  • Another variation of the stent is illustrated in FIG. 9. The bridge elements are evenly spaced throughout the stent, forming cells all of equal size and shape. However, apices (for example, [0052] 90 a and 90 b) of bridge elements 98 face opposite directions in adjacent pairs of segments 92.
  • FIG. 10 illustrates yet another variation of the stent, wherein U-shaped portions [0053] 100 a and 100 b of bridge elements 108 a and 108 b, respectively, are facing in opposite directions in adjacent pairs of segments 102 and wherein the cells formed at each end of the stent are of different size than those of the remaining cells. The bridge elements adjoining any pair of adjacent segments are evenly spaced, but the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size, and, in similar fashion to FIG. 8, produces regions of greater strength at either end of the stent.
  • It is generally preferable to align the bridge elements between adjacent sinusoidal segments with the apices pointing in the direction of a converging peak and valley of the adjacent segments. This configuration provides a number of advantages. One advantage is that, in the expanded configuration, the stent cell structure is sufficiently open to permit access to the lumen. For example, it is possible to manipulate catheters through the stent wall into vessel bifurcations in order to treat those vessels. Another advantage is that the stent geometry provides a smooth profile for delivery when in the contracted position. In the stent design of this invention, the U-shape of the connecting bridges lies between a converging valley and peak of adjacent sinusoidal segments and acts as a bridge therebetween. This reduces the chance of snagging any cellular matter from the inside of the lumen. The peaks or valleys of some prior art stents protrude especially when the stent is bent during delivery. This protruding peak or valley can snag on a vessel wall or plaque, making delivery and positioning of the stent difficult. A further advantage is provided by the configuration of the bridge elements. The connector arms and U-shaped portion of the bridge elements act in cooperation with the segments to provide an effective support surface for the vessel wall while at the same time minimizing the amount of stent material which must be used. [0054]
  • As to deployment (that is, the in situ expansion) of the stent, currently the most widely used method is to use a balloon catheter, disposing the stent about the balloon of the catheter in the contracted condition and then expanding the balloon once the stent has been delivered to the deployment site. Different solutions are also possible, such as using superelastic materials that expand when the stent reaches the implantation site. Typically these materials are held in a contracted condition by means of a containment element that is released when the stent has reached the desired location and position. Materials having a “shape memory” that expand from a first configuration to a second expanded configuration when heated to a transition temperature (i.e., body temperature) also may be used in order to achieve the radial expansion in the implant position. [0055]
  • Usually the stent is made from a metal capable of satisfying two fundamental requirements: the ability to deform during the expansion phase and the ability to resist forces which could lead to contraction of the stent. That is, the stent retains the expanded shape. For example, the stents of this invention may comprise 316 stainless steel or a shape memory material known under the commercial designation “Nitinol”. “Nitinol” is a nickel-titanium alloy that has been shown to be successful due to its superelasticity as well as its shape memory. Stents also may comprise biodegradable and/or biocompatible polymers, as known to one of skill in the art. [0056]
  • These technological aspects will not be dealt with in detail in the present description in that they are not in themselves relevant to the comprehension and production of the invention. This also applies essentially to the technology for the production of the stent according to the invention. As described above, the stent of this invention comprises a tubular body with an apertured wall. Methods of making the stent include: [0057]
  • forming the stent from a continuous tubular blank intended to be segmented into individual stents, with the apertured parts being formed using techniques such as laser incision, photo-incision, electroerosion, and the like; [0058]
  • forming the stent from a strip-like body in which the apertured zones are formed, for example, using the techniques listed above, with the subsequent closure of the strip-like element into a tube; and [0059]
  • forming the stent from metal wire shaped by the subsequent attachment of wire loops, for example, using operations of micro welding, brazing, gluing, crimping, and the like. [0060]
  • The first arrangement described is the one currently preferred for producing stents of this invention. In particular, the use of laser beams to cut a continuous tubular blank has been shown to be the most flexible way to modify rapidly the characteristics of the stent during production. [0061]
  • Such methods may be used to produce a stent having either constant or variable wall thickness, and, in either case, with wall material having different cross-sections. These methods include making the stent from a continuous tubular blank and machining, grinding, chemically etching, or electron discharge machining the tube to produce the desired pattern and also obtain sections of desired cross-section. Alternatively, a tubular blank having constant or variable thickness down its length could be laser cut to form the desired arrangement of segments and bridges. A stent could be formed and then the inside surface could be turned or micro-etched. [0062]
  • The production method is not critical to the stents of this invention, as they may be formed by any desired method. This applies to the choice of the individual techniques and the order in which the various operations (the production of the apertured parts, segmentation, possible folding of the strip-like element, etc.) are performed. [0063]
  • Although particular embodiments have been disclosed herein in detail, this has been done for purposes of illustration only, and is not intended to be limiting with respect to the scope of the appended claims, which follow. In particular, it is contemplated by the inventor that various substitutions, alterations, and modifications may be made to the invention without departing from the spirit and scope of the invention as defined by the claims. For example, the frequency, number, and location of bridge elements and sinusoidal segments may be varied as necessary to obtain the desired characteristics of the stent. [0064]

Claims (12)

What is claimed is:
1. A stent having a substantially tubular body defining a longitudinal axis comprising:
first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment;
a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment.
2. The stent of
claim 1
wherein the U-shaped portions of the plurality of bridge elements are oriented in the same direction.
3. The stent of
claim 1
further comprising a third annular segment connected to the second annular segment by a plurality of bridge elements, wherein the U-shaped portion of the plurality of bridge elements is oriented in one direction between the first and second annular segments and in the opposite direction between the second and third annular segments.
4. The stent of
claim 1
wherein the connector arm of the bridge element joins the annular segment at a zero point of the sinusoidal shape.
5. The stent of
claim 4
wherein each connector arm joins each annular segment at a zero point of the sinusoidal shape.
6. The stent of
claim 1
further comprising a third annular segment connected by bridge elements to the second annual segment, wherein the bridge elements join zero points separated by 360° between the first and second adjacent segments, and further wherein the bridge elements join zero points separated by 720° between the second and third adjacent segments.
7. A method of preventing restenosis in a vessel comprising:
providing a stent having a substantially tubular body defining a longitudinal axis, the stent comprising first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment, a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment;
advancing the tubular body in the contracted condition through the lumen of the vessel to an area of stenosis; and
deploying the tubular body within the lumen of the vessel by expanding the tubular body from the contracted to the expanded condition.
8. A method of making a stent comprising:
providing a tubular blank defining a longitudinal axis; and
forming the blank into first and second adjacent annular segments connected by a plurality of bridge elements, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment, the plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment.
9. The method of
claim 8
wherein the forming step is by a method selected from one of laser incision, photo-incision, and electroerosion.
10. A stent having a substantially tubular body defining a longitudinal axis comprising:
first and second adjacent annular segments, each segment having a substantially sinusoidal wave shape;
first and second bridge elements, the first bridge element having a first end connected to the first annular segment at a zero point of the sinusoidal wave shape and having a second end connected to the second annular segment at a zero point of the sinusoidal wave shape, the second bridge element having a first end connected to the first annular segment at a zero point of the sinusoidal wave shape spaced 360° from the connection of the first bridge element to the first annular segment and a second end connected to the second annular segment at a zero point of the sinusoidal wave shape spaced 360° from the connection of the first bridge element to the second segment, the first and second bridge elements and the portion of the first and second annular segments between the connection points of the bridge elements together defining a cell.
11. A stent having a substantially tubular body defining a longitudinal axis comprising:
a plurality of annular segments, each segment having a substatially sinusoidal wave shape;
a plurality of bridge elements, each bridge element having a first end connected to one annular segment at a zero point of the sinusoidal wave shape and a second end connected to an annular segment adjacent to the one annular segment at a zero point of the sinusoidal wave shape of the adjacent annular segment, the annular segments and bridge elements being configured such that when compression, flexure and torsion forces are applied to the stent they generate first maximum stress regions, second maximum stress regions, and third maximum stress regions, where the first, second, and third maximum stress regions do not overlap.
12. The stent of
claim 11
wherein each bridge element includes a U-shaped portion between first and second connector arms and wherein the first maximum stress regions are located about the peaks and valleys of the annular segments, the second maximum stress regions are located about the apex of the U-shaped portion of the bridge element and the third maximum stress regions are located about the points of connection of the bridge elements and annular segments.
US09/410,303 1997-04-29 1999-10-01 Stents for angioplasty Expired - Lifetime US6451049B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US09/410,303 US6451049B2 (en) 1998-04-29 1999-10-01 Stents for angioplasty
DK00120834T DK1088528T3 (en) 1999-10-01 2000-09-25 Stents for angioplasty
ES00120834T ES2274758T3 (en) 1999-10-01 2000-09-25 STENTS FOR ANGIOPLASTIA.
DE60031490T DE60031490T2 (en) 1999-10-01 2000-09-25 Stents for angioplasty
EP00120834A EP1088528B1 (en) 1999-10-01 2000-09-25 Stents for angioplasty
AT00120834T ATE343355T1 (en) 1999-10-01 2000-09-25 STENTS FOR ANGIOPLASTY
US10/159,969 US7273494B2 (en) 1997-04-29 2002-05-31 Stents for angioplasty
US11/860,805 US20080288048A1 (en) 1997-04-29 2007-09-25 Stents for angioplasty
US12/793,341 US20100241216A1 (en) 1997-04-29 2010-06-03 Stents for angioplasty

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/069,425 US6325821B1 (en) 1997-04-29 1998-04-29 Stent for angioplasty
US09/410,303 US6451049B2 (en) 1998-04-29 1999-10-01 Stents for angioplasty

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/069,425 Continuation-In-Part US6325821B1 (en) 1997-04-29 1998-04-29 Stent for angioplasty

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/159,969 Continuation US7273494B2 (en) 1997-04-29 2002-05-31 Stents for angioplasty

Publications (2)

Publication Number Publication Date
US20010044649A1 true US20010044649A1 (en) 2001-11-22
US6451049B2 US6451049B2 (en) 2002-09-17

Family

ID=23624143

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/410,303 Expired - Lifetime US6451049B2 (en) 1997-04-29 1999-10-01 Stents for angioplasty
US10/159,969 Expired - Lifetime US7273494B2 (en) 1997-04-29 2002-05-31 Stents for angioplasty

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/159,969 Expired - Lifetime US7273494B2 (en) 1997-04-29 2002-05-31 Stents for angioplasty

Country Status (6)

Country Link
US (2) US6451049B2 (en)
EP (1) EP1088528B1 (en)
AT (1) ATE343355T1 (en)
DE (1) DE60031490T2 (en)
DK (1) DK1088528T3 (en)
ES (1) ES2274758T3 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010044650A1 (en) * 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
US20020095207A1 (en) * 2001-01-15 2002-07-18 Yousuke Moriuchi Stent
US6589275B1 (en) * 1998-02-25 2003-07-08 William Cook Eurpoe Aps Stent device
US20050033415A1 (en) * 2001-06-13 2005-02-10 Pelton Brian Lee Double-butted superelastic nitinol tubing
US20060155365A1 (en) * 1996-09-19 2006-07-13 Jacob Richter Stent with variable features to optimize support and method of making such stent
US20060173531A1 (en) * 1996-09-19 2006-08-03 Jacob Richter Stent with variable features to optimize support and method of making such stent
US20070088430A1 (en) * 2003-03-19 2007-04-19 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent having mid-strut interconnecting members
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US20080262601A1 (en) * 2002-09-13 2008-10-23 Cully Edward H Stent Device with Multiple Helix Construction
US20100228338A1 (en) * 1998-03-27 2010-09-09 Ev3 Inc. Stents with tapered struts
US7951188B2 (en) 2000-05-03 2011-05-31 Abbott Cardiovascular Systems Inc. Intravascular stent
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US8298244B2 (en) 2006-10-26 2012-10-30 Tyco Healtcare Group Lp Intracorporeal grasping device
US8449905B2 (en) 2001-10-22 2013-05-28 Covidien Lp Liquid and low melting coatings for stents
US8632584B2 (en) 2002-07-19 2014-01-21 Dendron Gmbh Medical implant having a curlable matrix structure and method of use
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US20140114434A1 (en) * 2012-10-22 2014-04-24 Orbusneich Medical, Inc. Medical device for implantation into luminal structures
US20140277378A1 (en) * 2013-03-15 2014-09-18 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US20160220396A1 (en) * 2011-09-09 2016-08-04 Isis Innovation Limited Stent and method of inserting a stent into a delivery catheter
US20170100268A1 (en) * 2014-03-25 2017-04-13 World Medish Co., Ltd. Flexible stent
US9980835B2 (en) 2013-10-22 2018-05-29 Orbusneich Medical Inc. Medical device for implantation into luminal structures incorporating corrugated structural elements
WO2018143115A1 (en) * 2017-02-01 2018-08-09 学校法人加計学園岡山理科大学 Bioabsorbable stent
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
CN111818882A (en) * 2018-03-09 2020-10-23 维斯帕医疗公司 Implantable stent
US11020215B2 (en) * 2012-06-15 2021-06-01 Phraxis, Inc. Venous anchor devices forming an anastomotic connector
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
CN117224297A (en) * 2023-11-13 2023-12-15 太原理工大学 Lower limb artery stent with reverse combined structure

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
JP4636634B2 (en) 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド,インコーポレイテッド Intravascular stent
US6235053B1 (en) 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US20040106985A1 (en) 1996-04-26 2004-06-03 Jang G. David Intravascular stent
IT1289815B1 (en) * 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS
IT1292295B1 (en) * 1997-04-29 1999-01-29 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT
US6451049B2 (en) * 1998-04-29 2002-09-17 Sorin Biomedica Cardio, S.P.A. Stents for angioplasty
US6309414B1 (en) * 1997-11-04 2001-10-30 Sorin Biomedica Cardio S.P.A. Angioplasty stents
US6261319B1 (en) * 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US7815763B2 (en) * 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6193744B1 (en) * 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US7758627B2 (en) * 2000-03-01 2010-07-20 Medinol, Ltd. Longitudinally flexible stent
US8920487B1 (en) 2000-03-01 2014-12-30 Medinol Ltd. Longitudinally flexible stent
EP1132058A1 (en) 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Intravascular prothesis
CN2430175Y (en) * 2000-05-15 2001-05-16 臧式先 Medical tubular rack
JP4754714B2 (en) * 2000-06-01 2011-08-24 テルモ株式会社 Intraluminal indwelling
CA2416825C (en) * 2000-07-24 2012-10-02 Jeffrey Grayzel Stiffened balloon catheter for dilatation and stenting
US7766956B2 (en) 2000-09-22 2010-08-03 Boston Scientific Scimed, Inc. Intravascular stent and assembly
US6699278B2 (en) 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
US20040102834A1 (en) * 2001-02-01 2004-05-27 Ryoji Nakano Stent
US6740114B2 (en) * 2001-03-01 2004-05-25 Cordis Corporation Flexible stent
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6939373B2 (en) * 2003-08-20 2005-09-06 Advanced Cardiovascular Systems, Inc. Intravascular stent
DE60120955T3 (en) * 2001-07-20 2015-06-25 Cid S.P.A. stent
US7547321B2 (en) * 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
EP1310242A1 (en) 2001-11-13 2003-05-14 SORIN BIOMEDICA CARDIO S.p.A. Carrier and kit for endoluminal delivery of active principles
EP1348402A1 (en) * 2002-03-29 2003-10-01 Advanced Laser Applications Holding S.A. Intraluminal endoprosthesis, radially expandable, perforated for drug delivery
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
US9561123B2 (en) 2002-08-30 2017-02-07 C.R. Bard, Inc. Highly flexible stent and method of manufacture
US6878162B2 (en) 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US20040093056A1 (en) 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7527644B2 (en) * 2002-11-05 2009-05-05 Alveolus Inc. Stent with geometry determinated functionality and method of making the same
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US20040102831A1 (en) * 2002-11-22 2004-05-27 Murray Robert J. Stent having tapered edges
US6923829B2 (en) * 2002-11-25 2005-08-02 Advanced Bio Prosthetic Surfaces, Ltd. Implantable expandable medical devices having regions of differential mechanical properties and methods of making same
US20070239251A1 (en) * 2002-12-31 2007-10-11 Abbott Cardiovascular Systems Inc. Flexible stent
EP2253339B1 (en) 2003-02-21 2011-12-28 Sorin Biomedica Cardio S.r.l. A process for producing stents and corresponding stent
US7179286B2 (en) * 2003-02-21 2007-02-20 Boston Scientific Scimed, Inc. Stent with stepped connectors
US6862794B2 (en) 2003-03-03 2005-03-08 Medtronic Ave, Inc. Method for manufacturing an endovascular support device
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US7604660B2 (en) 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
US7789979B2 (en) * 2003-05-02 2010-09-07 Gore Enterprise Holdings, Inc. Shape memory alloy articles with improved fatigue performance and methods therefor
US20050060025A1 (en) * 2003-09-12 2005-03-17 Mackiewicz David A. Radiopaque markers for medical devices
US20050080479A1 (en) * 2003-09-29 2005-04-14 Feng James Q. Expandable endovascular stent
US7806918B2 (en) * 2003-09-30 2010-10-05 Merit Medical Systems, Inc. Removable stent
DE10352874B4 (en) * 2003-11-10 2008-03-27 Qualimed Innovative Medizinprodukte Gmbh stent
ITTO20040056A1 (en) 2004-02-05 2004-05-05 Sorin Biomedica Cardio Spa STENT FOR THE ENDOLIMINAL DELIVERY OF PRINCIPLES OR ACTIVE AGENTS
US7479158B2 (en) * 2004-02-20 2009-01-20 Boston Scientific Scimed, Inc. Stent with nested flexible connectors for flexibility and crimpability
EP1722711A4 (en) 2004-02-27 2009-12-02 Aortx Inc Prosthetic heart valve delivery systems and methods
DE102004012981B4 (en) * 2004-03-16 2009-01-02 Alveolus Inc. stent
DE102004022044B4 (en) * 2004-05-03 2008-12-18 Qualimed Innovative Medizinprodukte Gmbh stent
BRPI0418719A (en) * 2004-05-05 2007-09-11 Invatec Srl endoluminal prosthesis
US20050261757A1 (en) * 2004-05-21 2005-11-24 Conor Medsystems, Inc. Stent with contoured bridging element
US7780721B2 (en) 2004-09-01 2010-08-24 C. R. Bard, Inc. Stent and method for manufacturing the stent
DE102004045226B4 (en) * 2004-09-17 2008-01-17 Optiray Medizintechnik Gmbh support prosthesis
US7887579B2 (en) 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
US7731654B2 (en) 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
WO2007040249A1 (en) * 2005-10-06 2007-04-12 Kaneka Corporation Stent to be placed in the living body
EP3127508A1 (en) 2006-02-14 2017-02-08 Angiomed GmbH & Co. Medizintechnik KG Highly flexible stent
US20070191926A1 (en) * 2006-02-14 2007-08-16 Advanced Cardiovascular Systems, Inc. Stent pattern for high stent retention
US8147541B2 (en) 2006-02-27 2012-04-03 Aortx, Inc. Methods and devices for delivery of prosthetic heart valves and other prosthetics
US8403981B2 (en) 2006-02-27 2013-03-26 CardiacMC, Inc. Methods and devices for delivery of prosthetic heart valves and other prosthetics
CA2652871C (en) * 2006-05-12 2016-01-12 Cordis Corporation Balloon expandable bioabsorbable drug eluting flexible stent
GB0609841D0 (en) 2006-05-17 2006-06-28 Angiomed Ag Bend-capable tubular prosthesis
US8585594B2 (en) 2006-05-24 2013-11-19 Phoenix Biomedical, Inc. Methods of assessing inner surfaces of body lumens or organs
WO2007149841A2 (en) 2006-06-20 2007-12-27 Aortx, Inc. Torque shaft and torque drive
US8500799B2 (en) 2006-06-20 2013-08-06 Cardiacmd, Inc. Prosthetic heart valves, support structures and systems and methods for implanting same
AU2007260951A1 (en) 2006-06-21 2007-12-27 Aortx, Inc. Prosthetic valve implantation systems
US7988720B2 (en) 2006-09-12 2011-08-02 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US8778009B2 (en) * 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
GB0622465D0 (en) * 2006-11-10 2006-12-20 Angiomed Ag Stent
US9387100B2 (en) * 2007-01-08 2016-07-12 Cardinal Health Switzerland GmbH Intraluminal medical device having variable axial flexibility about the circumference of the device
US8328865B2 (en) 2007-02-12 2012-12-11 C. R. Bard, Inc. Highly flexible stent and method of manufacture
US8333799B2 (en) * 2007-02-12 2012-12-18 C. R. Bard, Inc. Highly flexible stent and method of manufacture
US8974514B2 (en) 2007-03-13 2015-03-10 Abbott Cardiovascular Systems Inc. Intravascular stent with integrated link and ring strut
US8016874B2 (en) * 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US7867273B2 (en) * 2007-06-27 2011-01-11 Abbott Laboratories Endoprostheses for peripheral arteries and other body vessels
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
JP2010540190A (en) 2007-10-04 2010-12-24 トリバスキュラー・インコーポレイテッド Modular vascular graft for low profile transdermal delivery
US8926680B2 (en) * 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
AU2009234268A1 (en) 2008-04-11 2009-10-15 Covidien Lp Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
US8114149B2 (en) * 2009-10-20 2012-02-14 Svelte Medical Systems, Inc. Hybrid stent with helical connectors
US8434906B2 (en) * 2010-02-23 2013-05-07 General Electric Company Lighting system with thermal management system
DE102011057026B4 (en) * 2011-12-23 2017-11-02 Acandis Gmbh & Co. Kg Medical device for insertion into a hollow body organ and manufacturing method
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
CN104490501A (en) * 2014-12-25 2015-04-08 周玉杰 Gradual changed thickness coronary stent suitable for coronary artery tortuosity angulation lesion
JP6965336B2 (en) 2016-03-31 2021-11-10 ヴェスパー メディカル、 インコーポレイテッドVesper Medical, Inc. Intravascular implant
US10238513B2 (en) 2017-07-19 2019-03-26 Abbott Cardiovascular Systems Inc. Intravascular stent
US10849769B2 (en) 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent
US11628076B2 (en) 2017-09-08 2023-04-18 Vesper Medical, Inc. Hybrid stent
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent
US11357650B2 (en) 2019-02-28 2022-06-14 Vesper Medical, Inc. Hybrid stent
US11364134B2 (en) 2018-02-15 2022-06-21 Vesper Medical, Inc. Tapering stent
IT201900003579A1 (en) 2019-03-12 2020-09-12 Alvimedica Tibbi Ueruenler Sanayi Ve Dis Ticaret A S STENT FOR CORONARY OSTIUM

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
SE450809B (en) 1985-04-10 1987-08-03 Medinvent Sa PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
EP0556940A1 (en) 1986-02-24 1993-08-25 Robert E. Fischell Intravascular stent
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4907336A (en) 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4830003A (en) 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
CA2380683C (en) 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
JP2825452B2 (en) 1994-04-25 1998-11-18 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Radiopak stent marker
WO1996014808A1 (en) 1994-11-09 1996-05-23 Endotex Interventional Systems, Inc. Delivery catheter and graft for aneurysm repair
CA2301351C (en) 1994-11-28 2002-01-22 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5728131A (en) 1995-06-12 1998-03-17 Endotex Interventional Systems, Inc. Coupling device and method of use
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5938682A (en) 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US5695516A (en) 1996-02-21 1997-12-09 Iso Stent, Inc. Longitudinally elongating balloon expandable stent
EP1477133B9 (en) 1996-03-05 2007-11-21 Evysio Medical Devices Ulc Expandable stent
US6334871B1 (en) 1996-03-13 2002-01-01 Medtronic, Inc. Radiopaque stent markers
NZ331269A (en) 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
DE69738786D1 (en) 1996-05-08 2008-07-31 Sorin Biomedica Cardio Srl A stent for angioplasty
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
IT1284708B1 (en) 1996-07-26 1998-05-21 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT
US5755781A (en) 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5776183A (en) 1996-08-23 1998-07-07 Kanesaka; Nozomu Expandable stent
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5755776A (en) 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
DE19648012A1 (en) 1996-11-20 1998-05-28 Bayer Ag Two-stage process for the production of semi-hard solid polyurethane moldings
IT1289728B1 (en) * 1996-12-10 1998-10-16 Sorin Biomedica Cardio Spa SYSTEM AND EQUIPMENT DEVICE THAT INCLUDES IT
FR2758253B1 (en) 1997-01-10 1999-04-02 Nycomed Lab Sa IMPLANTABLE DEVICE FOR THE TREATMENT OF A BODY DUCT
US5733330A (en) 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5759174A (en) 1997-01-29 1998-06-02 Cathco, Inc. Angioplasty balloon with an expandable external radiopaque marker band
DE29701758U1 (en) 1997-02-01 1997-03-27 Jomed Implantate Gmbh Radially expandable stent for implantation in a body vessel, particularly in the area of a vascular branch
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
DE29702671U1 (en) 1997-02-17 1997-04-10 Jomed Implantate Gmbh Stent
US5718713A (en) 1997-04-10 1998-02-17 Global Therapeutics, Inc. Surgical stent having a streamlined contour
DE19717477C2 (en) 1997-04-25 1999-12-09 Heraeus Gmbh W C Radially expandable support structure for keeping lumens open within a body
US6033433A (en) * 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
DE19717476C2 (en) 1997-04-25 1999-06-17 Heraeus Gmbh W C Radially expandable support structure
US6451049B2 (en) * 1998-04-29 2002-09-17 Sorin Biomedica Cardio, S.P.A. Stents for angioplasty
IT1292295B1 (en) * 1997-04-29 1999-01-29 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US5913895A (en) 1997-06-02 1999-06-22 Isostent, Inc. Intravascular stent with enhanced rigidity strut members
FR2764794B1 (en) 1997-06-20 1999-11-12 Nycomed Lab Sa EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS
IT1293973B1 (en) * 1997-08-13 1999-03-15 Sorin Biomedica Cardio Spa ELEMENT FOR ANCHORING OF INSTALLATION DEVICES IN SITU.
DE29716476U1 (en) 1997-09-13 1997-12-18 Convent Gerd Stenosis treatment stent
KR20010082497A (en) 1997-09-24 2001-08-30 메드 인스티튜트, 인코포레이티드 Radially expandable stent
US6309414B1 (en) * 1997-11-04 2001-10-30 Sorin Biomedica Cardio S.P.A. Angioplasty stents
US5938697A (en) 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6261319B1 (en) 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US6461380B1 (en) 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration
EP1579824A2 (en) 1999-06-30 2005-09-28 Advanced Cardiovascular Systems, Inc. Variable thickness stent and method of manufacture thereof

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534257B2 (en) 1996-09-19 2009-05-19 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US7998193B2 (en) 1996-09-19 2011-08-16 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US20060155365A1 (en) * 1996-09-19 2006-07-13 Jacob Richter Stent with variable features to optimize support and method of making such stent
US20060173531A1 (en) * 1996-09-19 2006-08-03 Jacob Richter Stent with variable features to optimize support and method of making such stent
US7976576B2 (en) 1996-09-19 2011-07-12 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US20100280593A1 (en) * 1996-09-19 2010-11-04 Medinol, Ltd. Stent with variable features to optimize support and method of making such stent
US20090024206A1 (en) * 1996-09-19 2009-01-22 Jacob Richter Stent with variable features to optimize support and method of making such stent
US6589275B1 (en) * 1998-02-25 2003-07-08 William Cook Eurpoe Aps Stent device
US9034029B2 (en) * 1998-03-27 2015-05-19 Covidien Lp Stents with tapered struts
US20100228338A1 (en) * 1998-03-27 2010-09-09 Ev3 Inc. Stents with tapered struts
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US7951188B2 (en) 2000-05-03 2011-05-31 Abbott Cardiovascular Systems Inc. Intravascular stent
US8449598B2 (en) 2000-05-03 2013-05-28 Abbott Cardiovascular Systems Inc. Intravascular stent
US20010044650A1 (en) * 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
US7431732B2 (en) * 2001-01-15 2008-10-07 Terumo Kabushiki Kaisha Stent with waved connecting members
US20020095207A1 (en) * 2001-01-15 2002-07-18 Yousuke Moriuchi Stent
US20050033415A1 (en) * 2001-06-13 2005-02-10 Pelton Brian Lee Double-butted superelastic nitinol tubing
US8900618B2 (en) 2001-10-22 2014-12-02 Covidien Lp Liquid and low melting coatings for stents
US9333279B2 (en) 2001-10-22 2016-05-10 Covidien Lp Coated stent comprising an HMG-CoA reductase inhibitor
US8449905B2 (en) 2001-10-22 2013-05-28 Covidien Lp Liquid and low melting coatings for stents
US10342683B2 (en) 2002-07-19 2019-07-09 Ussc Medical Gmbh Medical implant having a curlable matrix structure and method of use
US8632584B2 (en) 2002-07-19 2014-01-21 Dendron Gmbh Medical implant having a curlable matrix structure and method of use
US11426293B2 (en) 2002-07-19 2022-08-30 Ussc Medical Gmbh Medical implant
US20080262601A1 (en) * 2002-09-13 2008-10-23 Cully Edward H Stent Device with Multiple Helix Construction
US7980289B2 (en) * 2003-03-19 2011-07-19 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent having mid-strut interconnecting members
US20070088430A1 (en) * 2003-03-19 2007-04-19 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal stent having mid-strut interconnecting members
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US8298244B2 (en) 2006-10-26 2012-10-30 Tyco Healtcare Group Lp Intracorporeal grasping device
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US8940003B2 (en) 2008-02-22 2015-01-27 Covidien Lp Methods and apparatus for flow restoration
US11529156B2 (en) 2008-02-22 2022-12-20 Covidien Lp Methods and apparatus for flow restoration
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US9161766B2 (en) 2008-02-22 2015-10-20 Covidien Lp Methods and apparatus for flow restoration
US10456151B2 (en) 2008-02-22 2019-10-29 Covidien Lp Methods and apparatus for flow restoration
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US10426644B2 (en) 2010-10-01 2019-10-01 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US20160220396A1 (en) * 2011-09-09 2016-08-04 Isis Innovation Limited Stent and method of inserting a stent into a delivery catheter
US10383749B2 (en) * 2011-09-09 2019-08-20 Oxford University Innovation Limited Stent and method of inserting a stent into a delivery catheter
US11020215B2 (en) * 2012-06-15 2021-06-01 Phraxis, Inc. Venous anchor devices forming an anastomotic connector
CN104869945A (en) * 2012-10-22 2015-08-26 奥巴斯尼茨医学公司 Medical device for implantation into luminal structures
US20140114434A1 (en) * 2012-10-22 2014-04-24 Orbusneich Medical, Inc. Medical device for implantation into luminal structures
US10271975B2 (en) * 2013-03-15 2019-04-30 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US20140277378A1 (en) * 2013-03-15 2014-09-18 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US10842656B2 (en) 2013-03-15 2020-11-24 Atrium Medical Corporation Stent device having reduced foreshortening and recoil and method of making same
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US11304712B2 (en) 2013-09-13 2022-04-19 Covidien Lp Endovascular device engagement
US9980835B2 (en) 2013-10-22 2018-05-29 Orbusneich Medical Inc. Medical device for implantation into luminal structures incorporating corrugated structural elements
US10420660B2 (en) * 2014-03-25 2019-09-24 World Medish Technology Co., Ltd. Flexible stent
US20170100268A1 (en) * 2014-03-25 2017-04-13 World Medish Co., Ltd. Flexible stent
JPWO2018143115A1 (en) * 2017-02-01 2019-11-07 学校法人加計学園 岡山理科大学 Bioabsorbable stent
AU2018214780B2 (en) * 2017-02-01 2022-02-03 Japan Medical Device Technology Co., Ltd. Bioabsorbable stent
US11135075B2 (en) 2017-02-01 2021-10-05 Kake Educational Institution Okayama University Of Science Bioabsorbable stent
WO2018143115A1 (en) * 2017-02-01 2018-08-09 学校法人加計学園岡山理科大学 Bioabsorbable stent
JP2021517025A (en) * 2018-03-09 2021-07-15 ヴェスパー メディカル、 インコーポレイテッドVesper Medical, Inc. Implantable stent
CN111818882A (en) * 2018-03-09 2020-10-23 维斯帕医疗公司 Implantable stent
JP7373495B2 (en) 2018-03-09 2023-11-02 ヴェスパー メディカル、 インコーポレイテッド implantable stent
CN117224297A (en) * 2023-11-13 2023-12-15 太原理工大学 Lower limb artery stent with reverse combined structure

Also Published As

Publication number Publication date
ATE343355T1 (en) 2006-11-15
ES2274758T3 (en) 2007-06-01
EP1088528B1 (en) 2006-10-25
EP1088528A1 (en) 2001-04-04
DE60031490T2 (en) 2007-03-29
DK1088528T3 (en) 2007-02-26
US6451049B2 (en) 2002-09-17
DE60031490D1 (en) 2006-12-07
US20020183831A1 (en) 2002-12-05
US7273494B2 (en) 2007-09-25

Similar Documents

Publication Publication Date Title
US6451049B2 (en) Stents for angioplasty
US20080288048A1 (en) Stents for angioplasty
US7625398B2 (en) Endoprosthesis having foot extensions
US8048146B2 (en) Endoprosthesis having foot extensions
US7985249B2 (en) Endoprosthesis having foot extensions
EP1954223B1 (en) Stent configurations
US7625401B2 (en) Endoprosthesis having foot extensions
US7273492B2 (en) Stent for treating vulnerable plaque
EP1477136B1 (en) Longitudinally flexible expandable stent
JP3568899B2 (en) Medical device for intraluminal intravascular stent
US8075610B2 (en) Endoprosthesis for controlled contraction and expansion
US9427340B2 (en) Stent with protruding branch portion for bifurcated vessels
US20120143315A1 (en) Longitudinally flexible expandable stent
US20070073384A1 (en) Longitudinally flexible expandable stent
US20070135891A1 (en) Stent having an expandable web structure
US20110160840A1 (en) Repetitive Cell Bifurcation / Side Branch Ostia Support Stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: SORIN BIOMEDICA CARDIO S.P.A., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VALLANA, FRANCO;ROLANDO, GIOVANNI;CURCIO, MARIA;AND OTHERS;REEL/FRAME:010571/0376

Effective date: 20000105

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: SORIN BIOMEDICA CARDIO S.R.L., ITALY

Free format text: CHANGE OF NAME;ASSIGNOR:SORIN BIOMEDICA CARDIO S.P.A.;REEL/FRAME:021876/0393

Effective date: 20041006

AS Assignment

Owner name: INTERVASCULAR C.V., NETHERLANDS

Free format text: EXCERPTED ASSET PURCHASE AGREEMENT;ASSIGNOR:SORIN BIOMEDICA CARDIO S.R.L.;REEL/FRAME:022191/0138

Effective date: 20080610

AS Assignment

Owner name: INTERVASCULAR C.V., NETHERLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SORIN BIOMEDICA CARDIO S.R.L.;REEL/FRAME:022203/0679

Effective date: 20080610

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: CID S.P.A., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERVASCULAR C.V.;REEL/FRAME:029597/0790

Effective date: 20120917

FPAY Fee payment

Year of fee payment: 12